Dr. Ruxandra Ionescu, MD

NPI: 1093905408
Total Payments
$1,763
2024 Payments
$175.20
Companies
17
Transactions
85
Medicare Patients
2,980
Medicare Billing
$388,982

Payment Breakdown by Category

Food & Beverage$1,745 (99.0%)
Education$18.08 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,745 84 99.0%
Education $18.08 1 1.0%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $613.31 33 $0 (2024)
Actelion Pharmaceuticals US, Inc. $521.99 8 $0 (2018)
Sunovion Pharmaceuticals Inc. $176.54 18 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $105.21 1 $0 (2024)
PFIZER INC. $95.75 8 $0 (2021)
Genentech USA, Inc. $35.45 3 $0 (2018)
Inspire Medical Systems, Inc. $33.21 2 $0 (2024)
Octapharma USA, Inc. $24.05 1 $0 (2024)
Merck Sharp & Dohme Corporation $23.76 2 $0 (2021)
Teva Pharmaceuticals USA, Inc. $21.76 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $175.20 5 Takeda Pharmaceuticals U.S.A., Inc. ($105.21)
2023 $63.93 4 GlaxoSmithKline, LLC. ($47.79)
2022 $79.64 5 GlaxoSmithKline, LLC. ($61.15)
2021 $295.83 16 GlaxoSmithKline, LLC. ($176.45)
2020 $84.37 6 GlaxoSmithKline, LLC. ($65.70)
2019 $204.11 10 GlaxoSmithKline, LLC. ($192.49)
2018 $531.02 24 Actelion Pharmaceuticals US, Inc. ($319.36)
2017 $328.74 15 Actelion Pharmaceuticals US, Inc. ($202.63)

All Payment Transactions

85 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
11/13/2024 Octapharma USA, Inc. CUTAQUIG (Biological) Food and Beverage In-kind items and services $24.05 General
Category: IMMUNOLOGY
10/23/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $13.37 General
Category: IMMUNOLOGY
08/14/2024 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $105.21 General
07/11/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.50 General
Category: Respiratory
06/09/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $17.07 General
Category: NEUROLOGY
11/29/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $14.32 General
Category: IMMUNOLOGY
10/05/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $19.25 General
Category: IMMUNOLOGY
04/23/2023 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $16.14 General
Category: NEUROLOGY
02/07/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $14.22 General
Category: IMMUNOLOGY
12/02/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $14.41 General
Category: IMMUNOLOGY
10/12/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $13.42 General
Category: IMMUNOLOGY
07/08/2022 Chiesi USA, Inc. KENGREAL (Drug), CLEVIPREX Food and Beverage Cash or cash equivalent $18.49 General
Category: CARDIOVASCULAR
02/16/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $16.43 General
Category: IMMUNOLOGY
01/18/2022 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $16.89 General
Category: IMMUNOLOGY
12/08/2021 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $11.66 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/07/2021 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $11.47 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/24/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $14.72 General
Category: IMMUNOLOGY
09/22/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $13.03 General
Category: Cardiovascular
08/10/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $14.75 General
Category: IMMUNOLOGY
08/05/2021 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $13.87 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/04/2021 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $12.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/21/2021 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $5.59 General
Category: IMMUNOLOGY
07/19/2021 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Food and Beverage In-kind items and services $12.10 General
Category: INFECTIOUS DISEASE
07/16/2021 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $11.44 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/30/2021 United Therapeutics Corporation TYVASO (Drug) Education In-kind items and services $18.08 General
Category: PAH

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 628 1,024 $186,744 $82,563
2022 16 649 1,065 $197,363 $82,079
2021 16 795 1,321 $235,102 $109,642
2020 19 908 1,466 $250,063 $114,698
Total Patients
2,980
Total Services
4,876
Medicare Billing
$388,982
Procedure Codes
75

All Medicare Procedures & Services

75 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 120 263 $53,652 $23,526 43.8%
99291 Critical care, first 30-74 minutes Facility 2023 57 145 $49,300 $22,821 46.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 101 190 $24,700 $11,489 46.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 65 110 $17,600 $9,649 54.8%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 43 43 $11,610 $5,695 49.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 54 67 $8,710 $4,130 47.4%
94729 Test to examine how well the lungs exchange gases Office 2023 27 30 $2,850 $1,163 40.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 13 13 $2,275 $1,097 48.2%
94726 Test to determine lung volumes using sensors Office 2023 22 25 $2,375 $868.34 36.6%
94618 Test for exercise-induced lung stress Office 2023 20 22 $6,600 $547.76 8.3%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2023 18 19 $3,325 $506.34 15.2%
94375 Test to measure rate of airflow Office 2023 14 16 $1,456 $393.26 27.0%
G0008 Administration of influenza virus vaccine Office 2023 11 11 $385.00 $314.93 81.8%
36415 Insertion of needle into vein for collection of blood sample Office 2023 28 33 $396.00 $277.20 70.0%
85018 Blood count, hemoglobin Office 2023 23 25 $250.00 $58.00 23.2%
94761 Test to measure oxygen level in blood using ear or finger device multiple times Office 2023 12 12 $1,260 $28.11 2.2%
99291 Critical care, first 30-74 minutes Facility 2022 61 185 $62,760 $30,617 48.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 134 320 $65,280 $24,734 37.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 45 69 $11,040 $6,097 55.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 74 102 $13,350 $5,946 44.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 36 37 $9,990 $5,676 56.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 43 67 $8,710 $3,705 42.5%
94729 Test to examine how well the lungs exchange gases Office 2022 30 35 $3,225 $1,323 41.0%
94726 Test to determine lung volumes using sensors Office 2022 27 32 $2,865 $1,077 37.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 11 11 $1,925 $934.36 48.5%

About Dr. Ruxandra Ionescu, MD

Dr. Ruxandra Ionescu, MD is a Critical Care Medicine healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093905408.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruxandra Ionescu, MD has received a total of $1,763 in payments from pharmaceutical and medical device companies, with $175.20 received in 2024. These payments were reported across 85 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,745).

As a Medicare-enrolled provider, Ionescu has provided services to 2,980 Medicare beneficiaries, totaling 4,876 services with total Medicare billing of $388,982. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Pulmonary Disease
  • Location Greenwood, IN
  • Active Since 08/01/2007
  • Last Updated 01/13/2022
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1093905408

Products in Payments

  • OPSUMIT MACITENTAN (Drug) $521.99
  • NUCALA (Biological) $396.39
  • TRELEGY ELLIPTA (Drug) $204.38
  • LONHALA MAGNAIR (Drug) $87.79
  • ELIQUIS (Drug) $73.47
  • Utibron (Drug) $36.92
  • CHANTIX (Drug) $35.31
  • UTIBRON (Drug) $33.87
  • INSPIRE (Device) $33.21
  • Xolair (Biological) $24.65
  • CUTAQUIG (Biological) $24.05
  • QVAR (Drug) $21.76
  • DUPIXENT (Biological) $18.67
  • KENGREAL (Drug) $18.49
  • TYVASO (Drug) $18.08
  • BROVANA (Drug) $17.96
  • BREZTRI (Drug) $15.50
  • ANORO ELLIPTA (Drug) $12.54
  • SAMSCA (Drug) $12.31
  • RECARBRIO (Drug) $12.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Greenwood